Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · IEX Real-Time Price · USD
0.509
+0.019 (3.88%)
Mar 28, 2024, 3:59 PM EDT - Market closed

Catheter Precision Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016
Revenue
0.010.020.267.26.265.875.98
Revenue Growth (YoY)
-36.36%-91.51%-96.40%15.06%6.59%-1.77%-
Cost of Revenue
0.161.562.178.854.214.173.14
Gross Profit
-0.15-1.54-1.91-1.652.051.712.84
Selling, General & Admin
16.2515.4824.5351.5530.4414.955.32
Research & Development
6.3912.258.964.532.784.521.72
Other Operating Expenses
4.17000000
Operating Expenses
26.8127.7333.4956.0833.2119.477.04
Operating Income
-26.96-29.27-35.4-57.73-31.16-17.76-4.2
Interest Expense / Income
0000.250.0100
Other Expense / Income
-0.1-4.20.64-1.04-0.35--
Pretax Income
-26.86-25.07-36.04-56.94-30.82-17.76-4.2
Income Tax
000.010.020.0100
Net Income
-26.87-25.07-36.05-56.96-30.83-17.77-4.2
Shares Outstanding (Basic)
1000000
Shares Outstanding (Diluted)
1000000
Shares Change
923.76%197.23%223.00%42.47%22.33%8.54%-
EPS (Basic)
-25.98-248.22-1061.00-5414.00-4175.00-2937.50-750.00
EPS (Diluted)
-25.98-248.22-1061.00-5414.00-4175.00-2937.50-750.00
Free Cash Flow
-22.55-27.3-28.37-33.44-19.09-6.07-2.1
Free Cash Flow Per Share
-21.81-270.26-834.93-3178.80-2585.32-1005.63-376.91
Gross Margin
-1050.00%-6990.91%-738.61%-22.93%32.78%29.05%47.49%
Operating Margin
-192578.57%-133027.27%-13668.34%-801.92%-498.00%-302.56%-70.25%
Profit Margin
-191892.86%-113954.55%-13916.99%-791.18%-492.76%-302.64%-70.31%
Free Cash Flow Margin
-161050.00%-124072.73%-10954.05%-464.52%-305.10%-103.41%-35.07%
EBITDA
-26.44-23.5-33.67-54.94-30.18-17.54-4.1
EBITDA Margin
-188864.29%-106822.73%-13001.16%-763.19%-482.40%-298.84%-68.66%
Depreciation & Amortization
0.421.572.371.750.620.220.1
EBIT
-26.86-25.07-36.04-56.69-30.81-17.76-4.2
EBIT Margin
-191871.43%-113936.36%-13914.29%-787.50%-492.38%-302.56%-70.25%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).